TAKEDA ONCOLOGY 1POINT Trademark

Trademark Overview


On Monday, May 15, 2017, a trademark application was filed for TAKEDA ONCOLOGY 1POINT with the United States Patent and Trademark Office. The USPTO has given the TAKEDA ONCOLOGY 1POINT trademark a serial number of 87450064. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Friday, February 17, 2023. This trademark is owned by Takeda Pharmaceutical Company Limited. The TAKEDA ONCOLOGY 1POINT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information

Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services

Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; Providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders
takeda oncology 1point

General Information


Serial Number87450064
Word MarkTAKEDA ONCOLOGY 1POINT
Filing DateMonday, May 15, 2017
Status711 - CANCELLED - SECTION 7
Status DateFriday, February 17, 2023
Registration Number5891730
Registration DateTuesday, October 22, 2019
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements


Description of MarkThe mark consists of the word "TAKEDA" in stylized red font appearing inside of two red intersecting arcs, the lower with a straight line on the bottom and the upper curving arc being thicker in size and with two sides extending over the lower arc and the word "ONCOLOGY" appearing in black below; to the right is a grey vertical line, followed by the number"1" in white appearing in overlapping area of two triangles, one in grey and one in shades of red that are partially obstructed by the letter "P" in the word "POINT" appearing to the right of the triangles in red stylized lettering.
Pseudo MarkTAKEDA ONCOLOGY ONE POINT
Goods and ServicesFinancial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information
Indication of Colors claimedThe color(s) red, black, grey and white is/are claimed as a feature of the mark.
Goods and ServicesBusiness administration of patient reimbursement programs; business administration of medication reimbursement programs and services
Goods and ServicesProviding medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; Providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders
Disclaimer with Predetermined Text"ONCOLOGY"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, February 17, 2023
Primary Code035
First Use Anywhere DateMonday, August 27, 2018
First Use In Commerce DateMonday, August 27, 2018

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, February 17, 2023
Primary Code036
First Use Anywhere DateMonday, August 27, 2018
First Use In Commerce DateMonday, August 27, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, February 17, 2023
Primary Code044
First Use Anywhere DateMonday, August 27, 2018
First Use In Commerce DateMonday, August 27, 2018

Trademark Owner History


Party NameTakeda Pharmaceutical Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address540-8645
JP

Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address540-8645
JP

Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP

Trademark Events


Event DateEvent Description
Wednesday, March 15, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 15, 2023REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS NOT UPDATED
Friday, February 17, 2023CANCELLED SECTION 7-TOTAL
Wednesday, February 1, 2023NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Monday, January 6, 2020REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Thursday, February 13, 2020NOTICE OF CANCELLATION SEC. 8 EMAILED
Wednesday, February 12, 2020NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Monday, January 6, 2020REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Wednesday, February 5, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 6, 2020TEAS SECTION 7 SURRENDER RECEIVED
Tuesday, October 22, 2019REGISTERED-PRINCIPAL REGISTER
Friday, September 20, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 19, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2019SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2019SU - NON-FINAL ACTION - WRITTEN
Wednesday, February 20, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 29, 2019USE AMENDMENT FILED
Wednesday, February 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 29, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, August 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 9, 2018SOU EXTENSION 1 GRANTED
Thursday, August 9, 2018SOU EXTENSION 1 FILED
Thursday, August 9, 2018TEAS EXTENSION RECEIVED
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 15, 2017ASSIGNED TO LIE
Sunday, October 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 23, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 23, 2017NON-FINAL ACTION E-MAILED
Friday, June 23, 2017NON-FINAL ACTION WRITTEN
Saturday, June 17, 2017ASSIGNED TO EXAMINER
Saturday, May 20, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 18, 2017NEW APPLICATION ENTERED